GlassScriptPhysician profile
Timothy David Sharpe
NPI 1578898524
$5,466.83
in general payments reported to CMS, 2019-2025
20 companies · $1,508 in 2025
The $1,508 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $682 · 2022: $1,867 · 2023: $783 · 2024: $627 · 2025: $1,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,917.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $1,292.42 | 2022 | |
| Stryker Corporation | $1,099.17 | 2021-2025 | Mako, Trident |
| Davol INC. | $487.64 | 2022-2025 | Arista |
| Neurocrine Biosciences, INC. | $382.50 | 2023-2025 | Ingrezza |
| Glaxosmithkline, LLC. | $314.74 | 2022-2024 | Arexvy |
| Medtronic, INC. | $258.00 | 2023 | Cobalt Dr Mri Surescan |
| Vertex Pharmaceuticals Incorporated | $222.90 | 2025 | |
| Novo Nordisk INC | $202.96 | 2021 | |
| Abbott Laboratories | $152.12 | 2025 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $123.68 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $123.67 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $117.96 | 2023 | Nuedexta |
| Jazz Pharmaceuticals INC. | $115.27 | 2021 | |
| Esperion Therapeutics, INC. | $113.17 | 2021 | |
| Lima USA, INC. | $101.59 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $98.67 | 2025 | Rezdiffra |
| Amgen INC. | $90.51 | 2025 | Tezspire |
| Abbvie INC. | $84.93 | 2021 | |
| Coloplast Corp | $77.83 | 2024 | |
| Heron Therapeutics, INC. | $7.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Sharpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.